NEJM: Too Soon To Dismiss Vytorin Cancer Connection
According to an editorial published in the New England Journal of Medicine, it is too early to rule out concerns about a possible Vytorin cancer connection that was identified in…
According to an editorial published in the New England Journal of Medicine, it is too early to rule out concerns about a possible Vytorin cancer connection that was identified in…
The FDA released an early communication yesterday, about an investigation into the possible association between cancer and Vytorin, Zetia and Zocor.
The FDA issued an alert on Friday to remind doctors and the public about the risk of rhabdomyolysis, a rare and potentially fatal muscle condition, which could arise from the…
Merck & Co. and Schering Plough Corp., the joint marketers of the cholesterol drug Vytorin, have sent a letter to healthcare providers dismissing the potential increased risk of cancer identified…
A new study has found that cholesterol drug Vytorin provides no benefit in reducing the risk of major heart-valve problems, raising questions about why the drug is still on the…